These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 8809423

  • 1. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide.
    Lantero S, Sacco O, Scala C, Morelli MC, Rossi GA.
    Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients.
    Oddera S, Silvestri M, Sacco O, Lantero S, Morelli MC, Rossi GA.
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):33-40. PubMed ID: 7621058
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
    Lantero S, Sacco O, Scala C, Rossi GA.
    J Asthma; 1997 Jul; 34(2):141-52. PubMed ID: 9088301
    [Abstract] [Full Text] [Related]

  • 4. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R, Sabatini F, Silvestri M, Serpero L, Petecchia L, Rossi GA.
    Int Immunopharmacol; 2004 Dec 15; 4(13):1687-96. PubMed ID: 15454120
    [Abstract] [Full Text] [Related]

  • 5. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
    Powell N, Till SJ, Kay AB, Corrigan CJ.
    Clin Exp Allergy; 2001 Jan 15; 31(1):69-76. PubMed ID: 11167953
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C, Peterson CG, Dahlbäck M, Scheynius A, Alving K.
    Clin Exp Allergy; 1996 Dec 15; 26(12):1436-48. PubMed ID: 9027445
    [Abstract] [Full Text] [Related]

  • 7. Budesonide down-regulates eosinophil locomotion but has no effects on ECP release or on H2O2 production.
    Lantero S, Oddera S, Silvestri M, Gonzalez Rodriguez R, Morelli MC, Rossi GA.
    Lung; 1999 Dec 15; 177(4):219-28. PubMed ID: 10384060
    [Abstract] [Full Text] [Related]

  • 8. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH, Lin YH, Yang J, Guo W.
    Int Arch Allergy Immunol; 2009 Dec 15; 148(3):199-210. PubMed ID: 18849611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-5 receptors on human lung eosinophils after segmental allergen challenge.
    Julius P, Hochheim D, Böser K, Schmidt S, Myrtek D, Bachert C, Luttmann W, Virchow JC.
    Clin Exp Allergy; 2004 Jul 15; 34(7):1064-70. PubMed ID: 15248851
    [Abstract] [Full Text] [Related]

  • 15. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A, Shmilowich R, Shasha D, Frucht-Pery J, Pe'er J, Bonini S, Levi-Schaffer F.
    Invest Ophthalmol Vis Sci; 2000 Apr 15; 41(5):1038-44. PubMed ID: 10752939
    [Abstract] [Full Text] [Related]

  • 16. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.
    Clin Exp Allergy; 2006 Mar 15; 36(3):261-72. PubMed ID: 16499636
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ciclesonide modulates in vitro allergen-driven activation of blood mononuclear cells and allergen-specific T-cell blasts.
    Silvestri M, Morandi F, Pistoia V, Prigione I, Rossi GA.
    Immunol Lett; 2012 Jan 30; 141(2):190-6. PubMed ID: 22015638
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.